President - Psychedelic Medicine Association
Co-Founder and Executive Director, Thank You Life
Kevin Cannella is a MAPS-trained psychedelic psychotherapist who has been using non-ordinary states to help himself and others heal for 15 years. Kevin is the Executive Director and Co-Founder of Thank You Life, a psychedelic therapy nonprofit organization with a mission of eliminating the financial barriers to psychedelic therapy. His life’s work has been to help people align with their core values and transform.
CEO, Wellbeing Digital Sciences; Founder, KGK Science
Najla Guthrie is revolutionizing the way we treat and talk about wellness. Her extensive list of accomplishments include founding KGK Science, publishing over 50 papers in peer-reviewed journals, becoming the CEO of Wellbeing Digital Sciences, and her research on the effects of citrus juices and their constituent flavonoids on breast cancer cells.
Najla is a global leader in the nutraceutical and emerging psychedelic industry with a focus on how the development of natural compounds can fundamentally change the way we treat and prevent mental illness. She continues to present and speak at a global level, lobby for the advancement of policy changes in the supplement and cannabis industries, and lead the team at Wellbeing Digital Science and KGK Science.
Co-Founder & CEO, Psychedelic Support
Dr. Feduccia is a neuropharmacologist who has authored 24 publications on psychedelics and mental health in peer-reviewed journals. She began researching MDMA in 2004, accumulating 17 years of experience in mental health research at UT Austin, UCSF, NIH, and MAPS. In 2018, she co-founded Project New Day, a 501(c)3 nonprofit foundation with the mission to help people overcome addiction and actualize mental health through the responsible and legal use of psychedelics. Psychedelic Support is the integration of her long-standing plant medicine practice, anchored in the belief that psychedelics can heal the soul and help us humans evolve in harmony with the earth.
The Psychedelic Medicine Association’s mission is to educate healthcare professionals on psychedelic therapies as a means to increase patients’ ability to access these medicines when they are appropriate and available.
However, having knowledgeable healthcare providers is only one of many factors that impact accessibility. Additional factors include having enough therapists trained in psychedelic-assisted psychotherapy, having safe and legal access to the medicines, and having cost-effective ways to administer the medicines so that lack of financial resources doesn’t prevent patients from accessing them.
To discuss ways to increase accessibility in some of these areas, we have invited on guests who are currently using different means to help patients get the therapies they need.
They’ll help educate us on:
…and much more!
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, January 26th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. A link to the recording will be available afterward if you cannot make it to the live event.Hope to see you all on the 26th!
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.